Literature DB >> 23588407

MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation.

Yan Li Liu1, Weifeng Wu, Yimin Xue, Mengsha Gao, Yuluan Yan, Qing Kong, Yu Pang, Fan Yang.   

Abstract

Viral myocarditis (VMC) is a common cardiovascular disease, and microRNAs (miRNAs) have been postulated to be involved in its pathology. Using microarrays, we observed that miRNA-21 and -146b were upregulated in a murine model of VMC. We also found that miRNA-451 was downregulated. In vivo silencing of miRNA-21 and -146b resulted in less-severe VMC. Overexpression of miRNA-451 did not ameliorate the severity of VMC. Further work revealed that inhibition of miRNA-21 and -146b decreased the expression levels of Th17 and RORγt . Overexpression of miRNA-451 had no effect on IL-17 and RORγt expression. Inhibition of miRNA-21 and -146b might ameliorate myocardium inflammation by mediating downregulation of RORγt expression, indicating that these miRNAs are involved in the pathogenesis of murine VMC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588407     DOI: 10.1007/s00705-013-1695-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

Review 1.  MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.

Authors:  Sonia R Isaacs; Jie Wang; Ki Wook Kim; Congcong Yin; Li Zhou; Qing Sheng Mi; Maria E Craig
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 2.  Cellular microRNAs and picornaviral infections.

Authors:  Miao Wang; Zeqian Gao; Li Pan; Yongguang Zhang
Journal:  RNA Biol       Date:  2014-06-12       Impact factor: 4.652

Review 3.  Picornaviruses and RNA Metabolism: Local and Global Effects of Infection.

Authors:  Autumn C Holmes; Bert L Semler
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Circulating MicroRNAs: a Potential Biomarker for Cardiac Damage, Inflammatory Response, and Left Ventricular Function Recovery in Pediatric Viral Myocarditis.

Authors:  Lior Goldberg; Tal Tirosh-Wagner; Amir Vardi; Haya Abbas; Nir Pillar; Noam Shomron; Yael Nevo-Caspi; Gideon Paret
Journal:  J Cardiovasc Transl Res       Date:  2018-06-18       Impact factor: 4.132

Review 5.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 6.  Contribution of MicroRNAs to autoimmune diseases.

Authors:  Lucien P Garo; Gopal Murugaiyan
Journal:  Cell Mol Life Sci       Date:  2016-03-04       Impact factor: 9.261

7.  Heart Failure in Chronic Myocarditis: A Role for microRNAs?

Authors:  P van den Hoogen; F van den Akker; J C Deddens; J P G Sluijter
Journal:  Curr Genomics       Date:  2015-04       Impact factor: 2.236

8.  MicroRNA-21, T helper lineage and autoimmunity.

Authors:  Gopal Murugaiyan; Lucien P Garo; Howard L Weiner
Journal:  Oncotarget       Date:  2015

Review 9.  Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs.

Authors:  Deena Khan; S Ansar Ahmed
Journal:  Front Genet       Date:  2015-07-14       Impact factor: 4.599

10.  Expression Levels of MicroRNA-146b and Anti-Cardiac Troponin I in Serum of Children with Viral Myocarditis and Their Clinical Significance.

Authors:  Min Yan; Jing Wang; Suyun Wang; Yang Zhang; Ling Liu; Hua Zhao
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.